chrisvoncsefalvay/vaers-outcomes huggingface dataset:
the patient was treated by a healthcare provider for shingles; Information has been received from a lawyer regarding a case in litigation concerning a patient (pt) of unknown age and gender. No information was received regarding the pt's past medical history, concurrent conditions, or concomitant medication. The pt was inoculated with zoster vaccine live (ZOSTAVAX) (lot number, dosage, and route of administration not provided) on or about 21-MAY-2008 at a hospital, for the long-term prevention of shingles and zoster-related conditions. Subsequent on unspecified date, the pt was treated by a healthcare provider for shingles. As a direct and proximate result of the patient's  use of  the zoster vaccine live (ZOSTAVAX) vaccine, the pt had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies and other losses and damages.At the time of the report, the patient's outcome was not recovered. The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).  Additional information has been requested.
She developed a hard bump that feels like bone on the colar bone of her right arm 2 days after the shot. The same side as her shot. She also developed a low grade fever that has lasted longer than a month. No treatment that I'm aware of.
Approximately 25 minutes after receiving vaccine, patient experienced tenderness below the left clavicle (felt like a bad bruise).  BP 142/77 HR 69.  Tenderness subsiding approximately 20 minutes later.  BP 135/74 HR 59.  Patient clinically stable.  Patient released at 10:45am.
I had my vaccination on 10/14/2022. On 11/25/2022 I started to have the sniffles. On 11/26/2022 I woke up with a scratchy throat and a stuffed nose head congestions and lung congestion. I presently feel better on 04/04/2023.
Localized reaction on left upper arm sore redness, tenderness, bronchial reaction, constipation, wheezing, resolved with Epi Pen and Albuterol inhalation.
cheeks red,   caller states this is her cousin who just texted her to say her symptoms resolved
On 3/24/21, almost a week after my second vaccine shot, I had a seizure while sleeping in bed. I hadn?t had a seizure in over 30 years, and then only with a fever (I had febrile seizures as a child). My husband got some of it on video after being unsuccessful waking me.
Approximately four days after the second vaccine was given I had terrible Ringing/ Pulsatile Tinnitus in both my ears that sounds like a heartbeat. Extreme intense migraines for several days, hair started falling out after the first Moderna shot and getting worse.I?ve also had weird muscle twitches /tremors, pain in my calves and joints and feeling  very weak. My constant ringing has not let up and I had bouts of dizziness, ears also feel full.
No other AE reported for patient; dose of PEDV AX HIB had been administered after undergoing a temperature excursion; This spontaneous report was received from a nurse and refers to a 4 months old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 11-NOV-2020, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 ml, one time, lot # T000885 was confirmed to be valid, expiration date 29-MAY-2022 (formulation, route of administration and anatomical location were not reported) for prophylaxis.   Administered dose of vaccine underwent multiple temperature excursions above 47.0 degrees Fahrenheit (F) and below 36 degrees F: on 29-OCT-2020, 35.2 degrees F for 10 minutes, on 30-OCT-2020, 35.0 degrees F for 8 minutes and 49.5 degrees F for 26 minutes, on 03-NOV-2020, 35.2 degrees F for 6 minutes, on 04-NOV-2020, 47.8 degrees F for 21 minutes, on 06-NOV-2020, 35.0 degrees F for 9 minutes, on 09-NOV-2020, 50.0 degrees F for 81 minutes and 33.8 degrees F for 23 minutes.  The improper storage was recorded by digital data logger. There was no additional adverse event reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2011USA008619: US-009507513-2011USA008822:
Side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ADVERSE EVENT (Side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effect). At the time of the report, ADVERSE EVENT (Side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication use was provided by the reporter.  Treatment of events was not reported.
Pt developed urticarial lesions, 6 to 8 hours, post vax. Pt was afebrile and not sick looking. Treatment was Benadryl Elixir.
Information has been received from an office nurse concerning a 12 month old patient who on an unspecified date was vaccinated with varicella virus vaccine live (Oka/Merck) (lot# 658586/1272U). In January 2008, the patient experienced cellulitis at the injection site on the thigh. The patient was treated with an antibiotic (therapy unspecified). On an unspecified date the patient recovered. A product quality complaint was not reported. This is one of three reports from the same source. Additional information has been requested.
Fully vaccinated with Moderna, last dose given 2/4/21. Had a known household exposure and became symptomatic on 4/19/21, tested positive for covid on 4/20/21.
Gastrointestinal upset; Redness left arm; Puffiness left arm; Rash left arm; Tiredness; soreness in left arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Gastrointestinal upset), FATIGUE (Tiredness), VACCINATION SITE PAIN (soreness in left arm at injection site), VACCINATION SITE ERYTHEMA (Redness left arm) and VACCINATION SITE SWELLING (Puffiness left arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Irritable bowel syndrome, Crohn's disease and COPD.    On 07-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Aug-2021, the patient experienced FATIGUE (Tiredness) and VACCINATION SITE PAIN (soreness in left arm at injection site). On 17-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness left arm), VACCINATION SITE SWELLING (Puffiness left arm) and VACCINATION SITE RASH (Rash left arm). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Gastrointestinal upset). The patient was treated with HYDROCORTISONE ACETATE (CORTIZONE [HYDROCORTISONE ACETATE]) for Vaccination site rash, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Gastrointestinal upset), VACCINATION SITE ERYTHEMA (Redness left arm), VACCINATION SITE SWELLING (Puffiness left arm) and VACCINATION SITE RASH (Rash left arm) outcome was unknown and FATIGUE (Tiredness) and VACCINATION SITE PAIN (soreness in left arm at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by reporter. Treatment medication includes essential oils.
Post Tdap at RA/IM, arrived with c/o pain at site with erythema 22 cm. S x S of "aches" and "cold sweats" post 4 6 hours from Tdap on 7/6/15 at 1:40.
This spontaneous report as received from a physician via Poison and Drug Center refers to a 60 year old female patient with allergy to codeine. There was no information about the patient's pertinent medical history reported. On 12-MAR-2016, the patient was vaccinated with ZOSTAVAX (lot#, expiration date, dose and route of administration were not reported) frequency reported as once (also reported as 1 shot) in the arm. Concomitant therapies included TRAMADOL and doxycycline. On 12-MAR-2016, the patient experienced swelling and pain in her arm at the injection site. The swollen area was 3 cm (also reported as 3 inches in length on arm). She developed hardness at the injection site, and her ankles and knees became swollen. She stated, the her ankles were double than the normal size. On 15-MAR-2016, the patient developed diffuse bilateral leg swelling, also described as severe swelling of both legs, knees and ankle joints and "4+" pitting edema. The outcome of the events was reported as not recovered. The patient sought medical attention and called pharmacist. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
The patient received a children's dose from the Pfizer children's vial but should have received of an adult dose, the patient is 14 years old.
Even if I had the vaccine shot I still got it/ Suspected vaccination failure; had it, around neck, lasted a month (shingles); This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Even if I had the vaccine shot I still got it/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had it, around neck, lasted a month (shingles)). The outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 14-Mar-2023 This case was reported by a patient via interactive digital media. The patient stated that it was terrible as he or she had it. The patient had the vaccine shot and still got it around the neck and it lasted about a month. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up was not possible, as no contact details were available.
Dosing error (underage use); This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dosing error (underage use)) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dosing error (underage use)). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Dosing error (underage use)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
An attorney reported that a female patient received injections of Hib-titer (Hemophilus b conjugate vaccine(diphtheria crm 197 protein conjugate) and Acel-Imune (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) as a result of her childhood immunizations. It is alleged that, as a result of the Thimerosal and the mercury and/or other heavy metals contained in the vaccines, she had the following symptoms: severe learning disabilitities, impairments in social relatedness, language and communication difficulties, abnormal movements, sensory dysfunction, depressions, anxiety, hearing loss, severe bowel dysfunction, and other health disorders. The reporter also stated that the patient was also exposed to heavy metals from emissions from a chemical plant. These events were considered medically important. No further information was available as of the date this was reported.
VERTIFO; VISUAL DISTURBANCE Narrative; Patient endorsed severe headache, dizziness/ vertigo, and blurry vision. The symptoms have been constant since her vaccination on 4/8/21. Physician recommended ED for consideration of CT head to rule out venous sinus thrombosis. Patient travelling to outside ED today.
DOSE GIVEN OUTSIDE TEMPERATURE EXCURSION/ADMINISTERED A 6TH DOSE FROM VIAL; This spontaneous report received from a health care professional concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies the patient had no history of drug abuse/illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 31-DEC-2069) dose was not reported, administered on 05-APR-2021 08:00 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced dose given outside temperature excursion/administered a 6th dose froml. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of dose given outside temperature excursion/administered a 6th dose froml was not reported. This report was non-serious.
Prevnar 13 injection administered by the pharmacist was extremely painful. Two and a half months later I have ongoing pain in my arm when I extend or lift it. Nothing my doctor has suggested has helped. This injection has worsened my health which was fine before this!
Patient had routine labs done the morning following his injection and his wbc and platelet count were both low.  His wbc count was 2.25 and his platelet count was 32.  Patient was asymptomatic.  He was a new patient that had not seen a doctor in several years so there was no previous labs to compare.  Lab work was ordered as part of a yearly screening.
Information has been received from a physician concerning an "over 65 years old" patient who was vaccinated with PNEUMOVAX 23 (lot number not available). Subsequently the patient "experienced swelling at the injection site". At the time of the report, the patient recovered from swelling at the injection site. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports received from the same source. Additional information has been requested.
Pt's only real complaint: mild lightheadedness/dizziness.  No CP, SOB, cough, throat swelling, difficulty swallowing, stridor, syncope, neuro deficits, HA, fever, chills, nausea, vomiting or pain of any kind.   Patient was evaluated and workup was done in ED: EKG, CXR, labs.  Patient was observed for ~2 hours after which his symptoms were totally gone and patient was sent home with normal vitals and without complaints of any kind.
The booster vaccine that was given to the mother-in-law was expired; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The booster vaccine that was given to the mother-in-law was expired) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The booster vaccine that was given to the mother-in-law was expired). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (The booster vaccine that was given to the mother-in-law was expired) had resolved.            No concomitant medications were provided. No treatment medications were reported.
Dehydration, Coughing, Stuffy nose, mucous, HARD TO SWALLOW, ACHING MUSCLES
PATIENT SAID THAT SHE HAS ALWAYS HAD AN INJECTION SITE REACTION BUT THIS TIME IT WAS MUCH MORE. SHE ENDED UP WITH PAIN AND WENT TO THE ER AND THEY GAVE HER STEROID SHOT. SHE IS CLAIMING THAT SHE FEELS IT'S SETTLED IN HER JOINT BUT PATIENT HAS A PREVIOUS SHOULDER INJURY.
I  received the vaccine . Since I received the vaccine I have had the most painful ovulation, and menstruation cycle in my whole life I am mid thirty?s, I know my cycle and body extremely well. Nothing else in my life has changed except the vaccine.   I also visited my doctor this week and she has no explanation for my Sudden changes. A week after my initial shot I was near the end of my ovulation I was incapacitated for 4 hours unable to move and felt like my insides were cramping and stabbed, a heating pad helped to reduce the pain to a dull roar. I never fully recovered to a normal stomach there has been slight pain in my whole abdomen for over 2 weeks. I received my second dose (Tuesday) and then started menstruating Wednesday, my entire abdomen is extremely painful it goes through my whole body to my back from the pelvis to my mid back. It is like someone has punched me in abdomen 40 times and put knives in my back, like I said i have never experienced anything remotely close before my vaccine status changed.
really tired; the next day her daughter felt a little lightheaded; felt like she had flu symptoms; some body aches; under her daughter's armpit where her lymph nodes were swollen; she had a sore arm that night; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the parent.  A 21 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date Jan2021 (Batch/Lot number: unknown) at the age of 21 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Hashimoto's" (ongoing), notes: diagnosed when she was 15 years old. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Jan2021, outcome "unknown", described as "she had a sore arm that night"; FATIGUE (non-serious), outcome "unknown", described as "really tired"; DIZZINESS (non-serious), outcome "unknown", described as "the next day her daughter felt a little lightheaded"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "felt like she had flu symptoms"; PAIN (non-serious), outcome "unknown", described as "some body aches"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "under her daughter's armpit where her lymph nodes were swollen". It was unknown if therapeutic measures were taken as a result of pain in extremity, fatigue, dizziness, influenza like illness, pain, lymphadenopathy. Additional information: Patient was not taking medication for her Hashimoto's. She's right on the cusp of needing medication. She's being followed by a specialist. Reporter thought her daughter who was in nursing school received her vaccine a while ago, in Jan2021 and into Feb2021. By the third day, her daughter felt better. She was totally fine. Reporter thought her daughter may have reported her experience online. She remembered her daughter received her second Covid-19 vaccine right before Valentine's Day. Special details regarding this report were not known by the reporter.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
rash under her left breast; Redness; itchy red bumps; This case was reported by a consumer via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash, erythema and itchy rash. On an unknown date, the outcome of the rash was recovered/resolved and the outcome of the erythema and itchy rash were unknown.   It was unknown if the reporter considered the rash, erythema and itchy rash to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient herself. Age at vaccination was not reported. The patient stated that she received her first dose of Shingrix the other day. The patient stated that she now experienced a rash under her left breast. The patient also stated that she has redness and itchy red bumps. The patient stated that the rash was not there a few days ago. The patient inquirred if receiving the Shingrix vaccine could have caused this reaction. The patient also inquired if Shingrix vaccine made her contagious. The patient provided medical advice disclaimer.  The patient also provided Shingrix FAQ's information per content.  The patient was referred to health care professional. The reporter consented to follow up. The patient did provide permission to contact health care professional
Received 5yr vaccine on 2/2/11. Mom called with c/o "significant" vaccine reaction. Seen on 2/3/11 and diagnosed with probable vaccine reaction but due to the significance of reaction started on KEFLEX. Area also marked to monitor for spread. Rec BENADRYL & warm compresses.
Diffuse hives 3/23 - 3/25 worse 3/24 - 3/25 treated with ORAPRED.
purple discoloration to her right arm and right fingers; chills; redness across her chest and stomach; cap refill was sluggish; This is a spontaneous report from a contactable nurse. A 37-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot# EJ1685), via intramuscular on 18Dec2020 11:00 in right arm at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The most recent COVID-19 vaccine was administered in hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Employee reported purple discoloration to her right arm and right fingers. She reported her cap refill was sluggish. She stated she had chills and redness across her chest and stomach on 18Dec2020 at 16:00. The events result in Emergency room/department or urgent care. The patient received the treatment for the events. Outcome of events were unknown.